Manufacturer record
Glacier Pharmaceutical Pvt Ltd. G-5: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Glacier Pharmaceutical Pvt Ltd. G-5 were declared Not of Standard Quality between June 2025 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Glacier Pharmaceutical Pvt Ltd. G-5 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glavit Syrup100ml | GLV-230Mfg 2024-03 · Exp 2025-08 | The content of Thiamine Hydrochloride(i.e. 74.7% of the labelled amount) and the content of Cyanocobalamin (i.e 11.92% of the labelled amount) in the sample are less than the permissible limit.Labelling | FDA Lab , MumbaiCDSCO lab | Jun 2025 |
| Glavit Syrup 200ml | GLV-233Mfg 2024-04 · Exp 2025-09 | The content of Thiamine Hydrochloride(i.e. 63.8% of the labelled amount) and the content of Cyanocobalamin (i.e 13.34% of the labelled amount) in the sample are less than the permissible limit.Labelling | FDA Lab , MumbaiCDSCO lab | Jun 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.